Stay updated on Dolutegravir in Pregnancy Clinical Trial

Sign up to get notified when there's something new on the Dolutegravir in Pregnancy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dolutegravir in Pregnancy Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the efficacy evaluation of dolutegravir (DTG) in women with untreated HIV in late pregnancy. This change may reflect new information regarding the comparison between DTG and efavirenz-based regimens for pregnant women commencing cART.
    Difference
    0.1%
    Check dated 2024-06-06T14:38:21.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to a detailed description of eligibility criteria, explaining that researchers look for participants who meet specific health conditions or prior treatments. Additionally, it provides general information about clinical research and outlines the inclusion criteria for the study.
    Difference
    21%
    Check dated 2024-05-22T21:29:12.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T23:11:19.000Z thumbnail image

Stay in the know with updates to Dolutegravir in Pregnancy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dolutegravir in Pregnancy Clinical Trial page.